Published in Women's Health Weekly, July 27th, 1998
A review of the literature published from 1976 to July 1997 and addressing DDAVP use in pregnant women with DI was conducted by J.G. Ray of McMaster University in Ontario, Canada ("DDAVP Use During Pregnancy: An Analysis of its Safety for Mother and Child," Obstet Gynecol Surv, July 1998;53(7):450-455).
Fifty-three cases were evaluated in 20 journal papers. An average dose of 29 (mu)g/day administered intranasally in these women (range: 7.5-100 (mu)g/day) provided effective management of DI.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.